<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en-US" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">global-journal-of-medical-research-c-microbiology-pathology</journal-id>
<journal-title-group>
<journal-title>Global Journal of Medical Research - C: Microbiology &amp; Pathology</journal-title>
</journal-title-group>
<issn publication-format="print">0975-5888</issn>
<issn publication-format="electronic">2249-4618</issn>
<publisher><publisher-name>Global Journals Publishing Group Incorporated</publisher-name></publisher>
<self-uri xlink:href="https://globaljournals.org/journal-seo-export/jats/60057.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.34257/GJMRC60057</article-id>
<article-id pub-id-type="publisher-id">60057</article-id>
<title-group>
<article-title>Study of Î±-Amylase Inhibitory Activity of Fractions Purified by Chromatographic Methods of the Endophytic Fungus Penicillium Brevicaule Alba-CC200</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Iqbol</surname><given-names>Mukhammedov</given-names></name><xref ref-type="aff" rid="aff1" />
</contrib>
<contrib contrib-type="author"><name><surname>Tashkhan</surname><given-names>Gulyamova</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Dilaram</surname><given-names>Ruzieva</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Saodat</surname><given-names>Nasmetova</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Sarvinoz</surname><given-names>Turdimuhammadova</given-names></name></contrib>
</contrib-group>
<aff id="aff1">UZBEKISTAN, Andijan State University</aff>
<volume>23</volume>
<issue>C2</issue>
<fpage>15</fpage>
<lpage>20</lpage>
<abstract><p>In this study, the antidiabetic activity of purified fractions of the endophytic fungus Penicillium brevicaule alba-CC200 isolated from the plant Celosia cristata was investigated. Antidiabetic activity was evaluated by inhibition of α-amylase enzyme. The secondary metabolites of P. brevicaule alba-CC200 were partially purified by column chromatography and obtained fraction II inhibited α-amylase by 91.2%. High inhibitory activity was observed in fraction II and was determined to be cardiac glycosides and terpenoids by thin layer chromatography (TLC) and qualitative analysis. This requires a more precise study of the purified fractions using high-precision chromatographic methods.</p></abstract>
<kwd-group kwd-group-type="author-generated">
<kwd>a-amylase</kwd>
<kwd>a-glucosidase</kwd>
<kwd>column chromatography</kwd>
<kwd>TLC</kwd>
<kwd>cardiac glycosides</kwd>
<kwd>terpenoids.</kwd>
</kwd-group>
<self-uri content-type="pdf" xlink:href="https://doc.globaljournals.org/_60057/article/study-of-α-amylase-inhibitory-activity-of-fractions-purified-by-chromatographic-methods-of-the-end.pdf" />
<self-uri content-type="html" xlink:href="https://globaljournals.org/scholarly-articles/study-of-%ce%b1-amylase-inhibitory-activity-of-fractions-purified-by-chromatographic-methods-of-the-endophytic-fungus-penicillium-brevicaule-alba-cc200/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>In this study, the antidiabetic activity of purified fractions of the endophytic fungus Penicillium brevicaule alba-CC200 isolated from the plant Celosia cristata was investigated. Antidiabetic activity was evaluated by inhibition of Î±-amylase enzyme. The secondary metabolites of P. brevicaule alba-CC200 were partially purified by column chromatography and obtained fraction II inhibited Î±-amylase by 91.2%. High inhibitory activity was observed in fraction II and was determined to be cardiac glycosides and terpenoids by thin layer chromatography (TLC) and qualitative analysis. This requires a more precise study of the purified fractions using high-precision chromatographic methods.</p>
</sec>
</body>
</article>